Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Recruiting 5Unknown 4Not yet recruiting 4Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 2

Sponsor

Conditions

Breast Neoplasms 1296Carcinoma, Non-Small-Cell Lung 793Neoplasms 787Colorectal Neoplasms 760Stomach Neoplasms 587Carcinoma, Hepatocellular 581Prostatic Neoplasms 514Lung Neoplasms 466Pancreatic Neoplasms 421Rectal Neoplasms 336Recurrence 314Neoplasm Metastasis 308Leukemia, Myeloid, Acute 293Colonic Neoplasms 283Multiple Myeloma 280Lymphoma 276Esophageal Neoplasms 273Uterine Cervical Neoplasms 272Ovarian Neoplasms 263Melanoma 246Head and Neck Neoplasms 245Precursor Cell Lymphoblastic Leukemia-Lymphoma 210Brain Neoplasms 195Lymphoma, Large B-Cell, Diffuse 187Nasopharyngeal Carcinoma 182Leukemia 173Lymphoma, Non-Hodgkin 171Liver Neoplasms 165Glioblastoma 160Polycystic Ovary Syndrome 157

Interventions

toripalimab 1pembrolizumab 1Radiation 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × Thymic epithelial tumor × Clear all
NCT04667793 2023-04-04

Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Unknown
15 enrolled

Thymic epithelial tumor

NCT05446935 2022-09-19

CHOICE

Shanghai Zhongshan Hospital

Phase NA Unknown
37 enrolled

Thymic epithelial tumor

NCT03858582 2021-03-22

neoadjuvant_thymic Epithelial Tumor

Samsung Medical Center

Phase 2 Unknown
40 enrolled

Thymic epithelial tumor

NCT04517539 2020-08-18

Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors

Shanghai Cancer Hospital, China

Phase 2 Unknown
65 enrolled

Thymic epithelial tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡